Comparison of the sales profile of azithromycin before and during the COVID-19 pandemic in the interior of Bahia
DOI:
https://doi.org/10.5020/18061230.2023.13933Keywords:
COVID-19, Azithromycin, Assisted selling medicines, Use of medicationsAbstract
Objective: to characterize the profile of azithromycin sales during the COVID-19 pandemic and compare this profile with the previous year in a municipality in the interior of Bahia. Methods: This is a cross-sectional study with an analytical descriptive design. The sample data were extracted from the database of the National Controlled Products Management System of the National Health Surveillance Agency, municipality of Jequié, years 2019, 2020 and 2021. Pearson’s Chi-square test was used to compare the proportions of categorical variables. The relationship between continuous variables was carried out using the simple linear regression model. A significance level of 0.05 was adopted. Results: It was found that the coated tablet was the best-selling in all years, especially in 2020, representing 89% of sales; the 18-59 age group reached the highest frequency in 2020 with 73.5%. The prescriber’s class council was, predominantly, the Regional Council of Medicine, which had a total of 92.7% of prescriptions in 2019, 91.4% in 2020 and 92.2% in 2021. There was a statistical association between pharmaceutical form and sex. A correlation was observed between the quantity of azithromycin sold and the number of confirmed cases of COVID-19 (r=0.931, p<0.001, R2=0.867). Conclusion: There was an increase in the sale of the antimicrobial azithromycin, with a correlation between the quantity sold and the number of confirmed cases of COVID-19, linked to encouraging the irrational use of medicines, which reinforces the need to include the pharmacist as an agent essential in health promotion and health education actions
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Brasileira em Promoção da Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitted manuscripts must be exclusively destined to RBPS and are not allowed to be submitted to another journal. When submitting the manuscript, authors must include the Declaration of Responsibility and Assignment of Copyright signed by all authors. The document must describe individual contribution to the preparation of the manuscript and be submitted in a pdf format. The author may deposit the final version of the article with post-print peer review in any repository or website under the Creative Commons Attribution 4.0 International License.